Recent Finacing
Recent Raise
Dualyx is a Belgium-based biotech developing regulatory T cell therapies, advancing DT-001, a TNFR2-agonist antibody in IND-enabling studies, with additional Treg-targeting programs and academic-industrial collaborations.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
